AU Patent

AU641206B2 — Multiple dose injection pen

Assigned to Eli Lilly and Co · Expires 1993-09-16 · 33y expired

What this patent protects

Provided is a hypodermic syringe having the same general appearance as a pen which is specifically adapted to provide for multiple measured injections of materials such as insulin or human growth hormone. <IMAGE>

USPTO Abstract

Provided is a hypodermic syringe having the same general appearance as a pen which is specifically adapted to provide for multiple measured injections of materials such as insulin or human growth hormone. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
AU641206B2
Jurisdiction
AU
Classification
—
Expires
1993-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.